Data

A single arm phase II study of the efficacy of tamoxifen in triple negative (oestrogen receptor alpha negative, progesterone receptor negative, HER-2 negative) but oestrogen receptor beta positive metastatic breast cancer (ANZ 1001 SORBET)

Health Data Australia Contributor Records
Breast Cancer Trials (BCT) ; Phillips, Kelly-Ann ; Breast Cancer Trials (BCT)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.58080/FHK5-KA87&rft.title=A single arm phase II study of the efficacy of tamoxifen in triple negative (oestrogen receptor alpha negative, progesterone receptor negative, HER-2 negative) but oestrogen receptor beta positive metastatic breast cancer (ANZ 1001 SORBET)&rft.identifier=http://doi.org/10.58080/FHK5-KA87&rft.publisher=Breast Cancer Trials (BCT)&rft.description=Dataset of 5 women with metastatic breast cancer that is ERβ positive but ERα negative, PgR negative and HER-2 negative (triple negative breast cancer). Participants received tamoxifen 20mg daily. The primary objective was to assess the efficacy of tamoxifen in triple negative(oestrogen receptor alpha negative, progesterone receptor negative, HER-2 negative) but oestrogen receptor beta positive metastatic breast cancer.&rft.creator=Breast Cancer Trials (BCT) &rft.creator=Phillips, Kelly-Ann &rft.creator=Breast Cancer Trials (BCT) &rft.date=2023&rft.relation=https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12610000506099&rft_subject=Cancer therapy (excl. chemotherapy and radiation therapy)&rft.type=dataset&rft.language=English Access the data
Cite Saved to MyRDA Save to MyRDA

Full description

Dataset of 5 women with metastatic breast cancer that is ERβ positive but ERα negative, PgR negative and HER-2 negative (triple negative breast cancer). Participants received tamoxifen 20mg daily. The primary objective was to assess the efficacy of tamoxifen in triple negative(oestrogen receptor alpha negative, progesterone receptor negative, HER-2 negative) but oestrogen receptor beta positive metastatic breast cancer.

Notes

HeSANDA 1.0.0

Issued: 2023

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related Publications

Related Organisations

Related People

Subjects
Cancer therapy (excl. chemotherapy and radiation therapy) |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Other Information
Breast Cancer Trials (BCT)

ROR : https://ror.org/00j1vsg87

Breast Cancer Trials (BCT)

ROR : https://ror.org/00j1vsg87

Breast Cancer Trials (BCT)

ROR : https://ror.org/00j1vsg87

Identifiers
Similar data you may be interested in: